COM:ELITEPHARMA
Elite Pharmaceuticals
- Stock
Last Close
0.52
07/11 20:59
Market Cap
189.08M
Beta: -
Volume Today
459.25K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -96.58M - | 28.93M 129.96% | -683.01K 102.36% | 3.81M 658.00% | -3.67M 196.38% | -9.28M 152.62% | -2.24M 75.86% | 5.09M 327.13% | 8.90M 74.87% | 3.56M 59.97% | 20.11B 564,456.44% | |
depreciation and amortization | 453.75K - | 581.86K 28.23% | 666.46K 14.54% | 714.53K 7.21% | 996.41K 39.45% | 1.26M 26.15% | 1.51M 20.18% | 1.52M 0.93% | 1.43M 5.90% | 1.34M 6.27% | 1.47B 109,337.24% | |
deferred income tax | 90.77M - | -45.72M 150.37% | -7.51M 83.57% | -9.53M 26.81% | -4.65M 51.18% | 448.92K 109.65% | 1.11M 147.60% | -2.30M 306.84% | -2.17M 5.54% | 1.51B 69,609.23% | -19.99B 1,424.12% | |
stock based compensation | 82.95K - | 260.05K 213.51% | 907.03K 248.79% | 767.71K 15.36% | 1.17M 52.37% | 1.72M 46.84% | 1.03M 40.11% | 935.62K 9.05% | 781.48K 16.48% | 579.33K 25.87% | 8.35B 1,441,924.08% | |
change in working capital | 31.98K - | -163.15K 610.18% | 1.87M 1,248.36% | -4.56M 343.22% | 927.71K 120.36% | -942.15K 201.56% | -3.21M 240.33% | -2.06M 35.82% | -1.01M 50.92% | -2.03M 100.55% | ||
accounts receivables | -66.92K - | -714.37K 967.46% | 33.24K 104.65% | 596.24K 1,693.73% | 258.18K 56.70% | -545.93K 311.45% | -2.79M 410.15% | 610.47K 121.92% | 438.46K 28.18% | -36.64K 108.36% | 236.28M 645,028.49% | |
inventory | -574.34K - | -1.10M 91.44% | -261.73K 76.20% | -3.12M 1,092.94% | 1.52M 148.62% | 382.28K 74.82% | 373.25K 2.36% | -870.43K 333.20% | -1.73M 98.55% | -2.81M 62.56% | -3.38B 120,195.17% | |
accounts payables | 883.45K - | 1.81M 105.02% | -2.21M 222.09% | -925.09K 58.17% | 677.27K 173.21% | 61.00K 90.99% | 344.39K 464.56% | -1.77M 613.61% | 314.21K 117.76% | 1.34M 325.37% | 7.78B 582,060.70% | |
other working capital | -210.21K - | -160.52K 23.64% | 4.31M 2,787.13% | -1.11M 125.63% | -1.53M 37.98% | -839.51K 44.98% | -1.14M 35.68% | -29.06K 97.45% | -34.45K 18.52% | -516.02K 1,398.05% | ||
other non cash items | 1.02M - | 1.01M 0.84% | 1.98M 96.41% | 904.63K 54.35% | 420.38K 53.53% | 5.25K 98.75% | 2.08K 60.39% | 2.19K 5.05% | -1.42M 65,253.57% | -1.51B 105,901.76% | ||
net cash provided by operating activities | -4.22M - | -15.10M 258.16% | -2.77M 81.69% | -7.88M 185.09% | -4.81M 39.00% | -6.79M 41.25% | -1.79M 73.59% | 3.19M 278.05% | 6.51M 103.78% | 3.34M 48.70% | -3.28B 98,388.38% | |
investments in property plant and equipment | -560.45K - | -2.00M 256.30% | -1.95M 2.41% | -1.10M 43.31% | -274.85K 75.12% | -19.13K 93.04% | -34.95K 82.71% | -329.98K 844.07% | -498.57K 51.09% | -5.74M 1,050.62% | -809.65M 14,013.77% | |
acquisitions net | 67.20K - | |||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | 5M - | |||||||||||
other investing activites | 2.78K - | -123.92K 4,562.23% | -122 - | -2.48K 1,936.89% | 350K 14,184.51% | |||||||
net cash used for investing activites | -557.67K - | 2.88M 616.29% | -1.95M 167.69% | -1.10M 43.30% | -277.33K 74.90% | 330.87K 219.30% | -34.95K 110.56% | -262.78K 651.81% | -498.57K 89.73% | -5.74M 1,050.62% | -809.65M 14,013.77% | |
debt repayment | -1.51K - | -1.33M 87,623.43% | -614.13K 53.79% | -621.49K 1.20% | -632.50K 1.77% | -496.68K 21.47% | -748.44K 50.69% | -1.93M 157.27% | -667.13K 65.35% | -12.74M 1,809.18% | -350.17M 2,649.29% | |
common stock issued | 10M - | 13.24M 32.37% | 6.20M 53.16% | 7.59M 22.48% | 2.00M 73.66% | 2.09M 4.62% | 1.44M 31.27% | 42.22K 97.06% | 14.35M 33,893.32% | 39.33M 173.98% | 159.92M 306.66% | |
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 1.35M - | 838.81K 37.81% | 3.18M 278.72% | 1.10M 65.39% | 303.69K 72.38% | -28.73K 109.46% | 689.54K 2,500.14% | 1.01M 46.98% | -14.35M 1,516.21% | -24.89M 73.39% | 3.58B 14,469.01% | |
net cash used provided by financing activities | 11.35M - | 12.75M 12.33% | 8.76M 31.26% | 8.07M 7.88% | 1.67M 79.30% | 1.57M 6.24% | 689.54K 55.99% | -869.83K 226.15% | -667.13K 23.30% | 1.70M 355.15% | 3.39B 198,797.07% | |
effect of forex changes on cash | -1 - | -1 0% | -695.02M - | |||||||||
net change in cash | 6.57M - | 522.40K 92.05% | 4.05M 674.88% | -917.49K 122.67% | -3.42M 272.26% | -4.90M 43.32% | -1.14M 76.73% | 2.06M 280.93% | 5.34M 159.19% | -695.72K 113.02% | -705.59M 101,318.97% | |
cash at beginning of period | 369.02K - | 6.94M 1,781.12% | 7.46M 7.53% | 11.51M 54.23% | 10.59M 7.97% | 7.57M 28.54% | 2.68M 64.66% | 1.54M 42.58% | 3.60M 134.15% | 8.94M 148.50% | 8.24B 92,118.30% | |
cash at end of period | 6.94M - | 7.46M 7.53% | 11.51M 54.23% | 10.59M 7.97% | 7.18M 32.24% | 2.68M 62.73% | 1.54M 42.58% | 3.60M 134.15% | 8.94M 148.50% | 8.24M 7.78% | 7.54B 91,341.91% | |
operating cash flow | -4.22M - | -15.10M 258.16% | -2.77M 81.69% | -7.88M 185.09% | -4.81M 39.00% | -6.79M 41.25% | -1.79M 73.59% | 3.19M 278.05% | 6.51M 103.78% | 3.34M 48.70% | -3.28B 98,388.38% | |
capital expenditure | -560.45K - | -2.00M 256.30% | -1.95M 2.41% | -1.10M 43.31% | -274.85K 75.12% | -19.13K 93.04% | -34.95K 82.71% | -329.98K 844.07% | -498.57K 51.09% | -5.74M 1,050.62% | -809.65M 14,013.77% | |
free cash flow | -4.78M - | -17.10M 257.94% | -4.71M 72.43% | -8.99M 90.67% | -5.08M 43.44% | -6.81M 33.99% | -1.83M 73.15% | 2.86M 256.60% | 6.01M 109.85% | -2.40M 139.90% | -4.09B 170,515.42% |
All numbers in (except ratios and percentages)